New pill trial offers hope for stiff, painful back condition
NCT ID NCT05861102
Summary
This Phase 3 trial is testing whether a twice-daily pill called Jaktinib can better control the painful inflammation and stiffness of active ankylosing spondylitis compared to a placebo. It involves about 265 adults whose current treatments aren't working well enough. Participants take the study drug or a dummy pill for 16 weeks to see if it significantly improves their pain, function, and overall disease activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RenJi Hospital
Shanghai, Shanghai Municipality, 200001, China
Conditions
Explore the condition pages connected to this study.